343 related articles for article (PubMed ID: 12487525)
1. Increases in fluoroquinolone-resistant Neisseria gonorrhoeae--Hawaii and California, 2001.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2002 Nov; 51(46):1041-4. PubMed ID: 12487525
[TBL] [Abstract][Full Text] [Related]
2. Fluoroquinolone-resistance in Neisseria gonorrhoeae, Hawaii, 1999, and decreased susceptibility to azithromycin in N. gonorrhoeae, Missouri, 1999.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2000 Sep; 49(37):833-7. PubMed ID: 11012233
[TBL] [Abstract][Full Text] [Related]
3. Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Apr; 56(14):332-6. PubMed ID: 17431378
[TBL] [Abstract][Full Text] [Related]
4. Increases in fluoroquinolone-resistant Neisseria gonorrhoeae among men who have sex with men--United States, 2003, and revised recommendations for gonorrhea treatment, 2004.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2004 Apr; 53(16):335-8. PubMed ID: 15123985
[TBL] [Abstract][Full Text] [Related]
5. Cephalosporin susceptibility among Neisseria gonorrhoeae isolates--United States, 2000-2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Jul; 60(26):873-7. PubMed ID: 21734634
[TBL] [Abstract][Full Text] [Related]
6. Fluoroquinolone-resistant Neisseria gonorrhoeae--San Diego, California, 1997.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1998 May; 47(20):405-8. PubMed ID: 9622458
[TBL] [Abstract][Full Text] [Related]
7. From the Centers for Disease Control and Prevention. Increases in fluoroquinolone-resistant Neisseria gonorrhoeae--Hawaii and California, 2001.
JAMA; 2002 Dec; 288(23):2961-3. PubMed ID: 12492093
[No Abstract] [Full Text] [Related]
8. The epidemiology of fluoroquinolone-resistant Neisseria gonorrhoeae in Hawaii, 2001.
Newman LM; Wang SA; Ohye RG; O'Connor N; Lee MV; Weinstock HS
Clin Infect Dis; 2004 Mar; 38(5):649-54. PubMed ID: 14986248
[TBL] [Abstract][Full Text] [Related]
9. Multidrug-resistant Neisseria gonorrhoeae with decreased susceptibility to cefixime-Hawaii, 2001.
Wang SA; Lee MV; O'Connor N; Iverson CJ; Ohye RG; Whiticar PM; Hale JA; Trees DL; Knapp JS; Effler PV; Weinstock HS
Clin Infect Dis; 2003 Sep; 37(6):849-52. PubMed ID: 12955650
[TBL] [Abstract][Full Text] [Related]
10. Fluoroquinolone resistance in Neisseria gonorrhoeae--Colorado and Washington, 1995.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1995 Oct; 44(41):761-4. PubMed ID: 7565558
[TBL] [Abstract][Full Text] [Related]
11. Resistance trends in Neisseria gonorrhoeae in southwestern Ohio.
Herchline TE; Inkrott BP
Sex Transm Dis; 2010 Feb; 37(2):121-2. PubMed ID: 19901861
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of and associated risk factors for fluoroquinolone-resistant Neisseria gonorrhoeae in California, 2000-2003.
Bauer HM; Mark KE; Samuel M; Wang SA; Weismuller P; Moore D; Gunn RA; Peter C; Vannier A; DeAugustine N; Klausner JD; Knapp JS; Bolan G
Clin Infect Dis; 2005 Sep; 41(6):795-803. PubMed ID: 16107976
[TBL] [Abstract][Full Text] [Related]
13. Activity of gemifloxacin tested against Neisseria gonorrhoeae isolates including antimicrobial-resistant phenotypes.
Pottumarthy S; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2006 Feb; 54(2):127-34. PubMed ID: 16423492
[TBL] [Abstract][Full Text] [Related]
14. Fluoroquinolone-resistant Neisseria gonorrhoeae: the inevitable epidemic.
Ghanem KG; Giles JA; Zenilman JM
Infect Dis Clin North Am; 2005 Jun; 19(2):351-65. PubMed ID: 15963876
[TBL] [Abstract][Full Text] [Related]
15. Decreased susceptibility of Neisseria gonorrhoeae to fluoroquinolones--Ohio and Hawaii, 1992-1994.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1994 May; 43(18):325-7. PubMed ID: 8164636
[TBL] [Abstract][Full Text] [Related]
16. Emergence of quinolone-resistant Neisseria gonorrhoeae in Pakistan.
Jabeen K; Khan E; Hasan R
Int J STD AIDS; 2006 Jan; 17(1):30-3. PubMed ID: 16409676
[TBL] [Abstract][Full Text] [Related]
17. Fluoroquinolone resistance in Neisseria gonorrhoeae.
Knapp JS; Fox KK; Trees DL; Whittington WL
Emerg Infect Dis; 1997; 3(1):33-9. PubMed ID: 9126442
[TBL] [Abstract][Full Text] [Related]
18. Activity of faropenem tested against Neisseria gonorrhoeae isolates including fluoroquinolone-resistant strains.
Jones RN; Critchley IA; Whittington WL; Janjic N; Pottumarthy S
Diagn Microbiol Infect Dis; 2005 Dec; 53(4):311-7. PubMed ID: 16269221
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial resistance for Neisseria gonorrhoeae in the United States, 1988 to 2003: the spread of fluoroquinolone resistance.
Wang SA; Harvey AB; Conner SM; Zaidi AA; Knapp JS; Whittington WL; del Rio C; Judson FN; Holmes KK
Ann Intern Med; 2007 Jul; 147(2):81-8. PubMed ID: 17638718
[TBL] [Abstract][Full Text] [Related]
20. Emergence and spread of drug resistant Neisseria gonorrhoeae.
Deguchi T; Nakane K; Yasuda M; Maeda S
J Urol; 2010 Sep; 184(3):851-8; quiz 1235. PubMed ID: 20643433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
